PTEN and urothelial carcinoma: Studies reporting PTEN deletions in ≥ 25% of urothelial carcinomas have used either LOH [27, 36], a method where chromosome 10 aneuploidy can mimic a gene loss [37, 38] or have employed FISH with a highly sensitive threshold based on findings in normal cells [20].